- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on Bayer Aktienges Ads (BAYRY.PK)
by latest | most commented
-
BioMS: Hype or Hope?
-
FDA Calendar Updates: Amgen, Bayer, Biogen, Noveko, Peplin, Transdel
-
Bayer Launches New Anti-Clotting Drug in China
-
Six Contraception and Birth Control Stocks
-
FDA, Clinical Trial Updates: JNJ, INCY, MEDX, CYTX, AGN, PPHM
-
New MS Therapies: A Hard Pill to Swallow?
-
FDA and Clinical Trial Calendars: Favorable Vote for Sanofi's Multaq
-
FDA and Clinical Trial Updates: United Therapeutics Faces Delays
-
Will 2009 Be a Year for Pharma Currency Speculators?
-
9 Possible Pharma Deals for 2009
-
Pharmas and Biotech: Vying for Outsize Insulin Profits
-
Largest German Companies Trading in the U.S.
-
Reality Check on the Big Pharma Rumor Mill
-
Wall Street Breakfast: Must-Know News
-
Are Pfizer and Lilly's ED Drugs Suffering from the Economic Slowdown?
-
Ten Highest Yielding Pharma Stocks
-
Wall Street Breakfast: Must-Know News
-
OTC Market Offers Relief From Sarbanes-Oxley - Barron's
-
Barr Labs Prevails Over Bayer in Yasmin Case
-
Bayer's Deadly Drug Poses Challenge to FDA Safety Policies
-
Jatropha Being Developed as a New Biodiesel Source
-
Bayer Prevails Over Dr. Reddy's in Avelox Case
-
Another Safety Review on Tap for Bayer's Trasylol -- FDA Panel
-
Are Public Companies Wasting Domain Name Assets?
-
Bayer Ready to Cure Investors’ Headaches -- Barron’s
-
Medtronic Sales Fall Short
-
Bayer Buyout Rumors Materialize Again
-
Pet Stocks: Nine Ways to Make Money From Caring for Your Pets
-
Estimating Future Stock Returns
-
Eight Value Stock Picks from Audrey Kaplan of Rochdale Investment Management
-
Bayer Drug Bests Sanofi-Aventis's Lovenox in Study
-
In-Line With Strategy, Dow Chemical Acquires Bayer's Cellulose Business
-
Carbon Emission Disclosure: Public Companies 'Come Clean'
-
3 Rising Impotence Stocks
-
Companies Provide Hormone Therapy Options for Women
-
Will Bayer Buy Onyx, Its Nexavar Partner?
-
Biotech Week in Review: Onyx Is Star of the Week
-
Biotech Day In Review: Osiris Stem Cells Treatment Has Unexpected Results
-
Biotech Day In Review: Merger Monday
-
Onyx Doubles on Positive Cancer Drug News
-
Say Ach Ya To Germany: A Global Powerhouse